TET2 and hepatocellular carcinoma: The results showed that deletion of the TET2 genome was present in 50% of female HCC tissues (p = 4.40E‐10, n = 52), and deletion of the TET2 genome occurred in 40.60% of male HCC tissues (p = 2.85E‐34, n = 234) (Figure 5D).